adenine and gdp 366

adenine has been researched along with gdp 366 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Carlos, JAEG; Costa-Lotufo, LV; Leitão, A; Lima, K; Machado-Neto, JA	1

Other Studies

1 other study(ies) available for adenine and gdp 366

Article	Year
AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axis. Investigational new drugs, 2021, Volume: 39, Issue:4 Topics: Adenine; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Heterocyclic Compounds, 4 or More Rings; Humans; Indoles; Jurkat Cells; Leukemia, Myeloid, Acute; Phenylurea Compounds; Phosphatidylinositol 3-Kinase; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; RNA, Messenger; Stathmin; Time Factors; U937 Cells	2021

Article

Year

AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axis.

Investigational new drugs, 2021, Volume: 39, Issue:4

Topics: Adenine; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Heterocyclic Compounds, 4 or More Rings; Humans; Indoles; Jurkat Cells; Leukemia, Myeloid, Acute; Phenylurea Compounds; Phosphatidylinositol 3-Kinase; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; RNA, Messenger; Stathmin; Time Factors; U937 Cells

2021